The association between hormones and antipsychotic use: a focus on postpartum and menopausal women
- A. González-Rodríguez, M. Seeman
- Psychology, MedicineTherapeutic Advances in Psychopharmacology
- 1 January 2019
It is indicated that, within standard dose ranges, the combination of hormones and antipsychotics for postnatal and menopausal women suffering severe mental distress can be beneficial, and is safe.
Hypothalamic-pituitary-adrenal system, neurotrophic factors and clozapine response: association with FKBP5 and NTRK2 genes.
- M. Mitjans, R. Catalán, B. Arias
- Psychology, MedicinePharmacogenetics & Genomics
- 1 May 2015
The results suggest that genetic variability in FKBP5 and NTRK2 genes may partially explain clinical response to clozapine.
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis
- V. Soria, A. González-Rodríguez, J. Labad
- Medicine, PsychologyPsychoneuroendocrinology
- 1 July 2018
Cortical thickness in regions of frontal and temporal lobes is associated with responsiveness to cognitive remediation therapy in schizophrenia
- R. Penadés, N. Pujol, C. Junqué
- Psychology, MedicineSchizophrenia Research
- 1 March 2016
Suicidal Ideation and Suicidal Behaviour in Delusional Disorder: A Clinical Overview
- A. González-Rodríguez, O. Molina-Andreu, Víctor Navarro Odriozola, Cristóbal Gastó Ferrer, R. Penadés, R. Catalán
- Psychology, MedicinePsychiatry Journal
- 30 January 2014
Interestingly, the results support the notion that percentages of both suicidal ideation and behaviour in delusional disorder are similar to patients with schizophrenia.
Delusional disorder: an overview of affective symptoms and antidepressant use
- A. González-Rodríguez, O. Molina-Andreu, Víctor Navarro Odriozola, Cristóbal Gastó Ferrer, R. Penadés, R. Catalán
- Psychology, Medicine
- 1 December 2013
A high frequency of comorbid depression in delusional disorder and a low antidepressants prescription rate could be concluded, indicating the role of mood symptoms in clinical practice among delusional disorder patients.
Neuroimaging studies of cognitive remediation in schizophrenia: A systematic and critical review
- R. Penadés, A. González-Rodríguez, R. Catalán, B. Segura, M. Bernardo, C. Junqué
- Psychology, MedicineWorld Journal of Psychiatry
- 22 March 2017
Neuroimaging studies of cognitive remediation in patients with schizophrenia suggest a positive effect on brain functioning in terms of the functional reorganisation of neural networks.
Pharmacotherapy for schizophrenia in postmenopausal women
- A. González-Rodríguez, M. Seeman
- Medicine, PsychologyExpert Opinion on Pharmacotherapy
- 20 April 2018
Estrogen modulators may not help all symptoms of schizophrenia but are, nevertheless, relatively safe and, when used as adjuncts, help to keep antipsychotic doses low, thus reducing the side effect burden.
Antipsychotic response in delusional disorder and schizophrenia: a prospective cohort study.
- A. González-Rodríguez, R. Catalán, R. Penadés, V. Ruíz, M. Torra, M. Bernardo
- Psychology, MedicineActas espanolas de psiquiatria
- 2016
Both response percentages and required antipsychotic doses were similar between DD and schizophrenia and changes in positive symptoms were associated with clinical global improvement in the entire sample, and improvement in cognitive symptoms was correlated with global improvement exclusively in DD.
BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trial
- R. Penadés, I. López-Vílchez, M. Bernardo
- Psychology, MedicineSchizophrenia Research
- 1 December 2017
...
...